265
Participants
Start Date
March 15, 2012
Primary Completion Date
May 5, 2014
Study Completion Date
November 20, 2019
Gefitinib
Investigational Drug
Placebo
Matching placebo as comparator
Pemetrexed
Chemotherapy (concomitant therapy)
Cisplatin
Chemotherapy (concomitant therapy)
Research Site, Budapest
Research Site, Budapest
Research Site, Taipei
Research Site, Genova
Research Site, Rozzano
Research Site, Hamburg
Research Site, Madrid
Research Site, Majadahonda
Research Site, Málaga
Research Site, Taichung
Research Site, Seville
Research Site, Parma
Research Site, Zaragoza
Research Site, Pisa
Research Site, Lille
Research Site, Clermont-Ferrand
Research Site, Lyon
Research Site, Löwenstein
Research Site, Paris
Research Site, Villejuif
Research Site, Würzburg
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Shenyang
Research Site, Dalian
Research Site, Changchun
Research Site, Changchun
Research Site, Saint Petersburg
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Suzhou
Research Site, Hangzhou
Research Site, Wuhan
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Chengdu
Research Site, Chengdu
Research Site, Kunming
Research Site, Xi'an
Research Site, Ürümqi
Research Site, Shijiazhuang
Research Site, Taiyuan
Research Site, Hong Kong
Research Site, Shatin
Research Site, Perugia
Research Site, Roma
Research Site, Roma
Research Site, Fukuoka
Research Site, Kashiwa
Research Site, Sakaishi
Research Site, Sayama
Research Site, Sunto-gun
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Lead Sponsor
AstraZeneca
INDUSTRY